Sanofi agrees on manufacturing and packaging of Moderna COVID-19 vaccine in U.S.

April 28, 2021

Moderna, Inc. announced that it has entered into an agreement with Sanofi for fill/finish sterile manufacturing services and supply packaging for up to 200 million doses of the Moderna COVID-19 Vaccine in the U.S. beginning in September 2021. Sanofi will leverage its established manufacturing infrastructure at its site in Ridgefield, NJ.

Moderna has the release.